Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Long-Term Investments (2017 - 2018)

Historic Long-Term Investments for Amicus Therapeutics (FOLD) over the last 4 years, with Q2 2018 value amounting to $13.8 million.

  • Amicus Therapeutics' Long-Term Investments changed N/A to $13.8 million in Q2 2018 from the same period last year, while for Jun 2018 it was $13.8 million, marking a year-over-year change of. This contributed to the annual value of $17.5 million for FY2014, which is N/A changed from last year.
  • According to the latest figures from Q2 2018, Amicus Therapeutics' Long-Term Investments is $13.8 million.
  • In the past 5 years, Amicus Therapeutics' Long-Term Investments ranged from a high of $42.7 million in Q1 2018 and a low of $482000.0 during Q2 2015
  • For the 4-year period, Amicus Therapeutics' Long-Term Investments averaged around $15.4 million, with its median value being $15.1 million (2017).